Cargando…

Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case–control study and meta-analysis

Resistance to valproic acid (VPA), a first-line antiepileptic drug (AED), is occurring at an alarming rate, particularly in children. Signal nucleotide polymorphisms are considered crucial in this process. Therefore, we investigated whether the SCN1A polymorphism rs3812718 could be associated with V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhi Jian, Chen, Jie, Chen, Hai Liang, Zhang, Lin Yan, Xu, Duo, Jiang, Wen Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435549/ https://www.ncbi.nlm.nih.gov/pubmed/30413604 http://dx.doi.org/10.1042/BSR20181654

Ejemplares similares

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy
por: Lu, Yuan, et al.
Publicado: (2020)

Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis
por: Wen, Zhuangfei, et al.
Publicado: (2021)

Association Between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and Responsiveness to Antiepileptic Drugs: A Meta-Analysis
por: Li, Mengmeng, et al.
Publicado: (2021)

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid
por: Li, Hongliang, et al.
Publicado: (2015)

Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy
por: Lu, Jieluan, et al.
Publicado: (2021)

Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
por: Zhu, Jiahao, et al.
Publicado: (2023)

Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
por: Romoli, Michele, et al.
Publicado: (2019)

Valproic acid for children below 2 years of age with epilepsy
por: Muthaffar, Osama Y., et al.
Publicado: (2021)

Pharmacogenetics of uridine diphosphate glucuronosyltransferase (UGT2B7) genetic polymorphism on valproic acid pharmacokinetics in epilepsy
por: Munisamy, Murali, et al.
Publicado: (2014)

SCN9A rs6746030 Polymorphism and Pain Perception in Combat Athletes and Non-Athletes
por: Leźnicka, Katarzyna, et al.
Publicado: (2023)

Spectrum of SCN8A-Related Epilepsy
por: Morgan, Lindsey A., et al.
Publicado: (2015)

Homozygosity for the SCN10A Polymorphism rs6795970 Is Associated With Hypoalgesic Inflammatory Bowel Disease Phenotype
por: Gonzalez-Lopez, Eugene, et al.
Publicado: (2018)

The association of adjusted plasma valproic acid concentration with CYP2C9 gene polymorphism in patients with epilepsy: a systematic review and meta-analysis
por: Fang, Huihui, et al.
Publicado: (2021)

Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
por: Shen, Xianhuan, et al.
Publicado: (2022)

Evaluation of Cardiac Repolarization Indices in Epilepsy Patients Treated with Carbamazepine and Valproic Acid
por: Asoğlu, Ramazan, et al.
Publicado: (2020)

Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy
por: Fujimoto, Ayataka, et al.
Publicado: (2022)

Overexpression of Homer1b/c induces valproic acid resistance in epilepsy
por: Wang, Yan, et al.
Publicado: (2022)

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
por: Hill, Sophie F., et al.
Publicado: (2023)

AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China
por: Fan, Xiaomei, et al.
Publicado: (2021)

Epilepsy surgery in patient with monogenic epilepsy related to SCN8A mutation
por: Podkorytova, Irina, et al.
Publicado: (2022)

SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis
por: Zeng, Qi, et al.
Publicado: (2022)

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis
por: Xu, Yue-Long, et al.
Publicado: (2018)

Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies
por: Min, Li, et al.
Publicado: (2020)

Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment
por: Zuberi, Nudrat A., et al.
Publicado: (2017)

Polymorphisms of the SCN1A gene in children and adolescents with primary headache and idiopathic or cryptogenic epilepsy: is there a linkage?
por: Toldo, Irene, et al.
Publicado: (2011)

Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy
por: Sterjev, Z, et al.
Publicado: (2012)

Genotype-phenotype correlations in SCN8A-related epilepsy: a cohort study of Chinese children in southern China
por: Peng, Bing-wei, et al.
Publicado: (2022)

Modifier genes in SCN1A‐related epilepsy syndromes
por: de Lange, Iris M., et al.
Publicado: (2020)

COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data
por: Leng, Wei-Dong, et al.
Publicado: (2016)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015)

MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients
por: Wang, Xiaofeng, et al.
Publicado: (2017)

RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy
por: Wang, Yan, et al.
Publicado: (2019)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017)

The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population
por: Fang, Zhen, et al.
Publicado: (2016)

SCN1A IVS5N+5 G>A Polymorphism and Risk of Febrile Seizure and Epilepsy: A Systematic Review and Meta-Analysis
por: Hao, Jindou, et al.
Publicado: (2020)

Risk of Valproic Acid-Related Tremor: A Systematic Review and Meta-Analysis
por: Zhang, Chen qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5g3ddt956r3n1a5cndihk823n